Fig. 4From: Relebactam restores susceptibility of resistant Pseudomonas aeruginosa and Enterobacterales and enhances imipenem activity against chromosomal AmpC-producing species: analysis of global SMART 2018–2020Effect of relebactam on susceptibility of Pseudomonas aeruginosa and Enterobacterales species to imipenem. A Relebactam restores susceptibility to imipenem in imipenem-NS Pseudomonas aeruginosa and Enterobacterales species. B Relebactam decreases imipenem MIC values in imipenem-S species. C These effects result in increased free drug pharmacokinetic/pharmacodynamic target (%ƒT > MIC) attainment for imipenem. %ƒT, percentage of time of free drug; AmpC, Ambler class C β-lactamase; AUC, area under the concentration–time curve; MIC, minimum inhibitory concentration; NS, nonsusceptible; S, susceptibleBack to article page